International pharmaceutical company GM PHARMA has unveiled its renewed brand identity, marking a new chapter in its 27-year history. The central symbol of the new identity is DNA, representing life, progress, continuous development, scientific excellence and innovation. These principles define GM PHARMA’s mission and shape its vision for the future.

According to the company, the renewed visual identity is far more than a logo redesign. It reflects GM PHARMA’s journey since its foundation, from implementing advanced manufacturing technologies and adhering to international quality standards to investing in research and development and delivering products trusted by millions of patients and healthcare professionals in Georgia and international markets.

Today, GM PHARMA has one of the region’s most diverse pharmaceutical portfolios, comprising more than 130 brands and 220 dosage forms, covering major therapeutic areas as well as a broad range of dietary supplements.

Since 2017, the company has been the leader of Georgia’s pharmaceutical market in both sales volume and market value. GM PHARMA exports more than 100 products to international markets and operates representative offices in 11 countries: Uzbekistan, Tajikistan, Kyrgyzstan, Armenia, Moldova, Azerbaijan, Kazakhstan, Mongolia, Turkmenistan, Belarus, and Ukraine.

Every year, more than 14 million patients in Georgia and international markets use GM PHARMA’s medicines and dietary supplements, reflecting the strong trust placed in the company by both consumers and healthcare professionals.

As part of its long-term growth strategy, GM PHARMA aims to further expand its international presence by strengthening its position in Europe, Southeast Asia, South America, and Central America, creating new opportunities for the company’s global development.

GM PHARMA’s manufacturing facility in Tbilisi is one of the leading pharmaceutical production sites in the Caucasus region, featuring a fully integrated manufacturing cycle for solid dosage forms. The company holds all major national and international certifications and authorizations required for pharmaceutical manufacturing, including the Georgian National GMP Certificate, PIC/S GMP Certification, ISO 9001:2017, ISO 17025, and others.

Since its establishment, GM PHARMA has remained committed to its mission and core values: continuously improving quality and products through scientific expertise and industry best practices, while developing and delivering medicines that enhance patients’ quality of life and contribute to longer, healthier lives. As the pharmaceutical industry enters a new era of technological advancement, the company continues to invest in innovation and actively contribute to the development of modern healthcare.

GM PHARMA - Evolving continuously, just like life itself.

(Ad)